Chargement en cours...
Proteinase‐activated receptor 1: A target for repurposing in the treatment of COVID‐19?
In the search to rapidly identify effective therapies that will mitigate the morbidity and mortality of COVID‐19, attention has been directed towards the repurposing of existing drugs. Candidates for repurposing include drugs that target COVID‐19 pathobiology, including agents that alter angiotensin...
Enregistré dans:
| Publié dans: | Br J Pharmacol |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7361899/ https://ncbi.nlm.nih.gov/pubmed/32639031 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.15194 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|